RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (OTCPK: LLBT) today announced that the Company has recently provided patient cases to Nanyang Technical University to aid in the development of the First Warning System’s (FWS) interpretive analytical system. One objective is to make it more user friendly for women to assist in the detection of breast cancer.
